Clincosm LogoSign in Get a demo

Kinetic Analysis Due to Foot Dysfunction

Sponsor
Delta University for Science and Technology (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05161364
Collaborator
(none)
70
Enrollment
1
Location
4.6
Anticipated Duration (Months)
15.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of the current study is to examine the biomechanical changes of gait kinetics in patients with either partial foot amputation or peripheral neuropathy

Condition or Disease Intervention/Treatment Phase
  • Procedure: amputation
  • Other: neuropathy

Study Design

Study Type:
Observational
Actual Enrollment :
70 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Analysis of Gait Kinetics in Patients With Foot Dysfunction Either Physiological or Anatomical
Actual Study Start Date :
Sep 13, 2021
Anticipated Primary Completion Date :
Jan 1, 2022
Anticipated Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
A: PFA

partial foot amputation

Procedure: amputation
partial foot amputation

Other: neuropathy
peripheral neuropathy
B: PN

peripheral neuropathy

Other: neuropathy
peripheral neuropathy

Outcome Measures

Primary Outcome Measures

  1. GRF [5 minutes]

    Ground Reaction Force

  2. Planter Pressure [3 minutes]

    Peak Planter Pressure

  3. Planter Pressure distribution [4 minutes]

    Planter Pressure distribution

  4. Foot surface area [6 minutes]

    Foot surface area

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 65 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Partial foot amputees who didn"t receive physiotherapy and don"t use prosthesis. patients with PN grade (1-2) Age 40-65y Both sexes. Walking independently however, no walking aids were used during the testing procedures
Exclusion Criteria:
  • Foot amputation levels more proximal than tarso metatarsal joint. Less than 4 months after partial foot amputation. Foot amputees who use prosthesis or suffer from phantom pain. Active foot problems; ulcer, infection, or gangrene. Patients with PN who received physiotherapy or injections like Puerarin Major surgeries in lower limb that could affect either gait or balance like ACL, hip/knee arthroplasty Spine problems that could affect either gait or balance History of ankle sprain. Pathologies such as skin diseases, inflammatory diseases, congenital diseases, or neurological diseases rather than PN.

Fractures or dislocations. Symptomatic degenerative changes that require medications. BMI over 35. Inability of walking independently

Contacts and Locations

Locations

Site City State Country Postal Code
1 Delta university Gamasa Eldakahlyia Egypt

Sponsors and Collaborators

  • Delta University for Science and Technology

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Omar Mohamed Ali Elabd, Assistant lecturer, Delta University for Science and Technology
ClinicalTrials.gov Identifier:
NCT05161364
Other Study ID Numbers:
  • 0224786
First Posted:
Dec 17, 2021
Last Update Posted:
Dec 17, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Peripheral Nervous System Diseases

Study Results

No Results Posted as of Dec 17, 2021